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chemoradiation (60 Gy, 2 Gy per fraction). Ipsilateral (iSVZ), 
contralateral (cSVZ), and bilateral (bSVZ) SVZs were 
retrospectively segmented following two delineation 
methods: with (TH+) and without (TH-) temporal horns. Dose-
volume histograms were retrospectively generated on the 
original plans. Progression was defined according to the RANO 
criteria. Multivariate analysis using the Cox proportional 
hazards model including significant covariates in univariate 
analysis was assessed to examine the relationship between 
prognostic factors and time to progression (TTP). 
 
Results: Median age was 59 years (range: 25-85). Median 
follow-up, OS and TTP were 52.8 months (95% CI 43.4-61.1), 
26.2 months (95% CI 20.3-34.2) and 6.4 months (95% CI 4.4-
9.3), respectively. On univariate analysis, initial contact to 
SVZ was a poor prognostic factor for OS (20.5 vs 56.4 months, 
p = 0.011) and TTP (4.6 vs 12.9 months, p = 0.002). With TH- 
method, patients receiving mean dose to bSVZ greater than 
40 Gy had a significantly improved TTP, as well as patients 
whose V20 Gy to bSVZ was greater than 84% (17.7 months vs 
5.2 months, p = 0.017). On multivariate analysis, initial 
contact to SVZ and V20 Gy to bSVZ lesser than 84% remained 
poor prognostic factors for TTP (HR = 3.07, p = 0.012 and HR 
2.67, p = 0.047, respectively). 
 
Conclusion: Our results suggest that contact to SVZ, as well 
as insufficient bSVZ coverage such as a V20 Gy lower than 
84%, are independent poor prognostic factors for TTP. 
Therefore, targeting SVZ is of crucial interest for optimizing 
glioblastoma treatment. 
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Purpose or Objective: The accuracy in contouring the target 
is one of the key factors for the success of stereotactic 
radiosurgery (SRS). This is particularly important when 
delivering one large fraction of radiation with small or no 
margins, since the consequence of not defining the correct 
clinical target volume can be that intended treatment results 
are not achieved. Furthermore, accurate contouring of the 
relevant Organs-at-Risk (OARs) is essential to minimize any 
normal tissue toxicity. The aim of this study was to analyze 
and quantify the variability of target and OAR contouring for 
two lesions in the brain. 
 
Material and Methods: A multicenter analysis of the 
variability in contouring the target and the OARs for two 
typical cases of brain disorders, a cavernous sinus 
meningioma and a vestibular schwannoma was performed. 
Twelve Gamma Knife centers from around the world have 
participated in the study by contouring the targets and the 
OARs. The resulting treatment plans were analyzed with 
respect to the agreement in target and OARs contouring.  
The 50 %-agreement volume, AV50, and the common volume, 
AV100, together with the encompassing volume, AV100/N, 
were determined based on a binary analysis method. A novel 
metric for the variability in delineation defined as the 
Agreement-Volume-Index was introduced and additionally 
calculated. The variability of the contoured structures was 
also analyzed with respect to the position of their centers of 
mass (COMs). 
 
Results: Substantial disagreement in target delineation was 
observed with an Agreement-Volume-Index of 0.22 for the 
meningioma case and 0.50 for the vestibular schwannoma 
case, respectively. Very high disagreement was also observed 
for the delineation as OARs of the optic apparatus and 
cochlea with an Agreement-Volume-Index ranging from 0 to 
0.13. The disagreement was observed with respect to the 
shape, size and position of the contoured volumes. The 
resulting disagreement in target volumes was highest for the 
meningioma (range 5.29-7.80 cm3) while a lower disparity 
was observed for the schwannoma (range 3.56-4.48 cm3). 
The majority of structures analyzed displayed the highest 
disagreement of the COM in longitudinal direction. An 
illustration of the displacement of the COMs together with 
the common volume and encompassing volume is shown in 
Figure 1 for the cavernous sinus meningioma case. 
 
Figure 1. Illustration of the displacement of the COMs (red 
dots) together with the common volume (blue) and 
encompassing volume (green) for the cavernous sinus 
meningioma case. 
 
Conclusion: Differences in target and OARs contouring 
expressed using different parameters, including a novel 
metric, emphasize the importance of further investigating 
and standardizing the contouring in SRS. Therefore, clinically 
significant differences in target and OARs delineation might 
lead to the need of better contouring tools, education and 
standardized protocols in SRS. 
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Purpose or Objective: The latency, overall extent, and rate, 
of distant brain failure for non-small cell lung cancer patients 
undergoing SRS for brain metastases is not well 
characterized. We evaluated the impact of multiple pre-
treatment parameters including age, KPS, extracranial 
disease status (ECD), initial number of metastases, initial 
aggregate tumor volume, and histological/molecular 
subtypes, on distant brain failure. We also evaluated the 
impact of WBRT performed before, combined with, or after 
SRS.  
 
Material and Methods: The retrospective study population 
included 118 NSCLC patients with brain metastases treated 
with SRS between 11/2008 and 01/2014. The distant brain 
metastasis-free survival (DBMFS) was defined as latency in 
months from initial SRS to first subsequent radiographic 
evidence of new brain metastasis. The extent of overall 
distant brain failure (ODBF) was defined as the total number 
of new metastases that developed following initial SRS 
treatment. The distant brain failure rate (DBFR) was defined 
as the ODBF/RFI where RFI was defined as the maximum 
radiographic follow-up interval in months. Kaplan Meir 
analysis was used to evaluate DBMFS and Log Rank test was 
used to determine the significance (p-value <0.05 was 
considered significant). For ODBF and DBFR, Independent 
